Results 241 to 250 of about 156,110 (291)
Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
Abstract Objective To characterize the clinical, electroencephalographic, and genetic features of epilepsies featuring absence seizures within monogenic etiology, highlighting the diagnostic, treatment and prognostic implications. Methods We conducted a retrospective, multicenter study including patients with monogenic epilepsies and ...
Simona Balestrini +50 more
wiley +1 more source
Internet Searches for Lorazepam Following the Release of The White Lotus.
Yang KH +4 more
europepmc +1 more source
Dexmedetomidine for Alcohol Withdrawal: Looks Can Be Deceiving. [PDF]
Riggan M +4 more
europepmc +1 more source
GABA and benzodiazepine receptors in basal ganglia function
Anne B. Young +3 more
openalex +2 more sources
Abstract Objectives Drug‐resistant epilepsy (DRE) remains a major clinical challenge, affecting approximately one‐third of patients with epilepsy. Cenobamate, a novel antiseizure medication (ASM) approved in Italy in 2022, has shown promise in clinical trials. However, real‐world data on its use, especially economic evaluations, remain limited.
Valentina Perrone +27 more
wiley +1 more source
Respiratory dysfunction and fatal apnea during pilocarpine‐induced status epilepticus
Abstract Objective Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure‐related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine‐induced SE affects respiration in mice.
Chengsan Sun +6 more
wiley +1 more source
Changes in benzodiazepine, z-drug, and other sedative prescribing in primary care in Ireland between 2014 and 2022. [PDF]
Mattsson M +9 more
europepmc +1 more source
Abstract Objective Developmental and epileptic encephalopathy with spike–wave activation in sleep ((D)EE‐SWAS) is associated with acquired cognitive and behavioral deficits. This international multicenter study aimed to compare cognitive and safety outcomes following initial treatment with corticosteroid and clobazam in patients not eligible for the ...
Marleen M. L. van Arnhem +18 more
wiley +1 more source

